FDA earlier questioned 'heart-healthy' cholesterol-lowering claims Does anybody really think a breakfast cereal will lower cholesterol? Two New Jersey residents swear they fell ...
NEW YORK (Reuters Health) - A US study on cholesterol released today contains both good and bad news: The good news: Between 1999 ...
ORLANDO, Florida (Reuters) - The good news for Merck & Co's Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical trial. The bad news is they think patient anxiety will cause its sales ...
A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work. In the study, Zetia failed to shrink buildups in ...
Dietary supplements get closer look A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost ten percent. Selenium is a trace essential mineral with anti-oxidant ...
NEW YORK (Reuters Health) - Fasting every other day can help obese people lose weight, a small study hints. Even though the study participants ate whatever they wanted on their non-fasting days, they lost an average of 5.6 kilograms (about 12 pounds) ...
U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck disclosed the rare move by the Food and Drug Administration in a regulatory filing Monday. ...
Keeping cholesterol low may help men avoid aggressive prostate cancers, study suggests Men may protect more than their hearts if they keep cholesterol in line: Their chances of getting aggressive prostate cancer may be lower, new research suggests. One study found that ...
CHICAGO (Reuters Life!) - Low total cholesterol may be a sign of cancer rather than a cause, as some researchers have suggested, and men who have low cholesterol actually have a lower risk of developing high-risk prostate cancer, two teams reported on ...
Merck is set to close $41B purchase of Schering-Plough, becoming world's No. 2 drugmaker Merck & Co. is set to complete its $41 billion acquisition of Schering-Plough Corp. later Tuesday, creating the world's second-largest drugmaker, behind Pfizer Inc. The companies expect the ...
Merck: FDA won't accept its application for combo cholesterol pill including Pfizer's Lipitor U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug. Merck disclosed the ...
Impax says it filed for approval of cholesterol drug, leading to patent suit from Abbott Impax Laboratories Inc. confirmed Friday it is challenging the patents on Abbott Laboratories' cholesterol drug TriCor, and that Abbott is suing Impax for patent infringement. Impax, of ...
